Radiomics Beyond the Hype: A Critical Evaluation Toward Oncologic Clinical Use.

IF 8.1 Q1 COMPUTER SCIENCE, ARTIFICIAL INTELLIGENCE Radiology-Artificial Intelligence Pub Date : 2024-07-01 DOI:10.1148/ryai.230437
Natally Horvat, Nikolaos Papanikolaou, Dow-Mu Koh
{"title":"Radiomics Beyond the Hype: A Critical Evaluation Toward Oncologic Clinical Use.","authors":"Natally Horvat, Nikolaos Papanikolaou, Dow-Mu Koh","doi":"10.1148/ryai.230437","DOIUrl":null,"url":null,"abstract":"<p><p>Radiomics is a promising and fast-developing field within oncology that involves the mining of quantitative high-dimensional data from medical images. Radiomics has the potential to transform cancer management, whereby radiomics data can be used to aid early tumor characterization, prognosis, risk stratification, treatment planning, treatment response assessment, and surveillance. Nevertheless, certain challenges have delayed the clinical adoption and acceptability of radiomics in routine clinical practice. The objectives of this report are to (<i>a</i>) provide a perspective on the translational potential and potential impact of radiomics in oncology; (<i>b</i>) explore frequent challenges and mistakes in its derivation, encompassing study design, technical requirements, standardization, model reproducibility, transparency, data sharing, privacy concerns, quality control, as well as the complexity of multistep processes resulting in less radiologist-friendly interfaces; (<i>c</i>) discuss strategies to overcome these challenges and mistakes; and (<i>d</i>) propose measures to increase the clinical use and acceptability of radiomics, taking into account the different perspectives of patients, health care workers, and health care systems. <b>Keywords:</b> Radiomics, Oncology, Cancer Management, Artificial Intelligence © RSNA, 2024.</p>","PeriodicalId":29787,"journal":{"name":"Radiology-Artificial Intelligence","volume":null,"pages":null},"PeriodicalIF":8.1000,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11294952/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Radiology-Artificial Intelligence","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1148/ryai.230437","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"COMPUTER SCIENCE, ARTIFICIAL INTELLIGENCE","Score":null,"Total":0}
引用次数: 0

Abstract

Radiomics is a promising and fast-developing field within oncology that involves the mining of quantitative high-dimensional data from medical images. Radiomics has the potential to transform cancer management, whereby radiomics data can be used to aid early tumor characterization, prognosis, risk stratification, treatment planning, treatment response assessment, and surveillance. Nevertheless, certain challenges have delayed the clinical adoption and acceptability of radiomics in routine clinical practice. The objectives of this report are to (a) provide a perspective on the translational potential and potential impact of radiomics in oncology; (b) explore frequent challenges and mistakes in its derivation, encompassing study design, technical requirements, standardization, model reproducibility, transparency, data sharing, privacy concerns, quality control, as well as the complexity of multistep processes resulting in less radiologist-friendly interfaces; (c) discuss strategies to overcome these challenges and mistakes; and (d) propose measures to increase the clinical use and acceptability of radiomics, taking into account the different perspectives of patients, health care workers, and health care systems. Keywords: Radiomics, Oncology, Cancer Management, Artificial Intelligence © RSNA, 2024.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
eRadiomics 超越炒作:面向肿瘤临床应用的严格评估。
"刚刚接受 "的论文经过同行评审,已被接受在《放射学》上发表:人工智能》上发表。这篇文章在以最终版本发表之前,还将经过校对、排版和校对审核。请注意,在制作最终校对稿的过程中,可能会发现影响内容的错误。放射组学是肿瘤学中一个前景广阔、发展迅速的领域,涉及从医学影像中挖掘定量高维数据。放射组学具有改变癌症管理的潜力,放射组学数据可用于辅助早期肿瘤特征描述、预后判断、风险分层、治疗计划、治疗反应评估和监测等。然而,放射组学在常规临床实践中的临床应用和可接受性还面临着一些挑战。本报告的目的是(a) 展望放射组学在肿瘤学领域的转化潜力和潜在影响;(b) 探讨放射组学发展过程中经常遇到的挑战和失误,包括研究设计、技术要求、标准化、模型可重复性、透明度、数据共享、隐私问题、质量控制,以及多步骤流程的复杂性导致放射科医生界面不够友好;(c) 讨论克服这些挑战和错误的策略;以及 (d) 考虑到患者、医护人员和医疗系统的不同观点,提出提高放射组学临床应用和可接受性的措施。©RSNA,2024 年。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
16.20
自引率
1.00%
发文量
0
期刊介绍: Radiology: Artificial Intelligence is a bi-monthly publication that focuses on the emerging applications of machine learning and artificial intelligence in the field of imaging across various disciplines. This journal is available online and accepts multiple manuscript types, including Original Research, Technical Developments, Data Resources, Review articles, Editorials, Letters to the Editor and Replies, Special Reports, and AI in Brief.
期刊最新文献
Integrated Deep Learning Model for the Detection, Segmentation, and Morphologic Analysis of Intracranial Aneurysms Using CT Angiography. RSNA 2023 Abdominal Trauma AI Challenge Review and Outcomes Analysis. SCIseg: Automatic Segmentation of Intramedullary Lesions in Spinal Cord Injury on T2-weighted MRI Scans. Combining Biology-based and MRI Data-driven Modeling to Predict Response to Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer. Optimizing Performance of Transformer-based Models for Fetal Brain MR Image Segmentation.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1